- Service Name
Tumor Treating Fields (TTFields)
- Industry
Healthcare, Oncology, Cancer Therapy, Medical Devices
- Main Value Proposition
Novocure offers a groundbreaking therapy that aims to improve survival rates for patients with aggressive cancers through innovative technology.
- Description
Novocure is an oncology company that develops and commercializes Tumor Treating Fields, a novel cancer therapy aimed at extending survival in aggressive forms of cancer. Their innovative approach targets solid tumors through non-invasive electrical fields.
- Key Features
Non-invasive treatment method; Targets multiple types of solid tumors; Proven anti-mitotic effects in clinical research; Ongoing clinical trials for various cancers
- Use Cases
The service is most valuable for patients diagnosed with aggressive cancers such as glioblastoma, pancreatic cancer, and non-small cell lung cancer, particularly those seeking alternative treatment options.
- Competitive advantages
Innovative non-invasive treatment option; Extensive clinical trial data supporting efficacy; Focus on patient-centered care and outcomes
- Strengths
Novocure's strengths lie in its pioneering technology, commitment to patient care, and a strong pipeline of clinical trials that explore various cancer types.
- Positioning
Novocure positions itself as a leader in oncology innovation, focusing on advanced therapies that improve patient survival and quality of life.
- Audience
The target users include cancer patients, caregivers, oncologists, and healthcare providers who are looking for innovative treatment solutions.
- CTA
Learn more
- Tags
cancer therapy
oncology
Tumor Treating Fields
patient care
- Tagline
Together with our patients, we strive to extend survival in some of the most aggressive forms of cancer.
- Tone of Voice
Compassionate, innovative, authoritative
- Differentiation
What makes Novocure unique is its focus on Tumor Treating Fields, a therapy that utilizes electric fields to disrupt cancer cell division, which is distinct from traditional chemotherapy and radiation treatments.
- Brand Positioning
The brand identity emphasizes innovation, patient-centric care, and a commitment to redefining cancer treatment through advanced technology.
- Founded
2000-01-01
- Founders
William F. Doyle
Yoram Palti